$5.45
-0.24-4.22%
At close: -
$5.45
0.000.00%
After Hours: Jan 24, 4:02 PM EDT
Comments
Loading...
Acrivon Therapeutics (NASDAQ:ACRV) Stock, Earnings Estimates, EPS, And Revenue
Acrivon Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$-0.700
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Acrivon Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Acrivon Therapeutics (ACRV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.59 | $-0.58 | -1.72 % |
| Q2 | 2024-08-13 | $-0.52 | $-0.60 | 13.3 % |
| Q1 | 2024-05-14 | $-0.73 | $-0.84 | 13.1 % |
| Q4 | 2024-03-28 | $-0.86 | $-0.73 | -17.8 % |
Acrivon Therapeutics (ACRV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics (ACRV) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Acrivon Therapeutics (NASDAQ:ACRV)?
The Actual EPS was $-0.59, which missed the estimate of $-0.58.
What were Acrivon Therapeutics’s (NASDAQ:ACRV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.